Flowers DA - Search Results

1

Loss of heterozygosity in childhood de novo acute myelogenous leukemia.

Sweetser DA, Chen CS, Blomberg AA, Flowers DA, Galipeau PC, Barrett MT, Heerema NA, Buckley J, Woods WG, Bernstein ID, Reid BJ. Sweetser DA, et al. Among authors: flowers da. Blood. 2001 Aug 15;98(4):1188-94. doi: 10.1182/blood.v98.4.1188. Blood. 2001. PMID: 11493469 Free article.

2

Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy: a phase I study of an anti-CD33 calicheamicin immunoconjugate.

Sievers EL, Appelbaum FR, Spielberger RT, Forman SJ, Flowers D, Smith FO, Shannon-Dorcy K, Berger MS, Bernstein ID. Sievers EL, et al. Blood. 1999 Jun 1;93(11):3678-84. Blood. 1999. PMID: 10339474 Free article. Clinical Trial.

3

Multidrug-resistance phenotype and clinical responses to gemtuzumab ozogamicin.

Linenberger ML, Hong T, Flowers D, Sievers EL, Gooley TA, Bennett JM, Berger MS, Leopold LH, Appelbaum FR, Bernstein ID. Linenberger ML, et al. Blood. 2001 Aug 15;98(4):988-94. doi: 10.1182/blood.v98.4.988. Blood. 2001. PMID: 11493443 Free article.

4

Differences in the frequency of normal and clonal precursors of colony-forming cells in chronic myelogenous leukemia and acute myelogenous leukemia.

Bernstein ID, Singer JW, Smith FO, Andrews RG, Flowers DA, Petersens J, Steinmann L, Najfeld V, Savage D, Fruchtman S, et al. Bernstein ID, et al. Among authors: flowers da. Blood. 1992 Apr 1;79(7):1811-6. Blood. 1992. PMID: 1373089 Free article.

5

Expression of lymphoid-associated cell surface antigens by childhood acute myeloid leukemia cells lacks prognostic significance.

Smith FO, Lampkin BC, Versteeg C, Flowers DA, Dinndorf PA, Buckley JD, Woods WG, Hammond GD, Bernstein ID. Smith FO, et al. Among authors: flowers da. Blood. 1992 May 1;79(9):2415-22. Blood. 1992. PMID: 1571553 Free article.

6

SIRT1 is dispensable for function of hematopoietic stem cells in adult mice.

Leko V, Varnum-Finney B, Li H, Gu Y, Flowers D, Nourigat C, Bernstein ID, Bedalov A. Leko V, et al. Blood. 2012 Feb 23;119(8):1856-60. doi: 10.1182/blood-2011-09-377077. Epub 2012 Jan 4. Blood. 2012. PMID: 22219225 Free PMC article.

7

Multidrug resistance protein attenuates gemtuzumab ozogamicin-induced cytotoxicity in acute myeloid leukemia cells.

Walter RB, Raden BW, Hong TC, Flowers DA, Bernstein ID, Linenberger ML. Walter RB, et al. Among authors: flowers da. Blood. 2003 Aug 15;102(4):1466-73. doi: 10.1182/blood-2003-02-0396. Epub 2003 Apr 10. Blood. 2003. PMID: 12689934 Free article.

8

CD33 expression and P-glycoprotein-mediated drug efflux inversely correlate and predict clinical outcome in patients with acute myeloid leukemia treated with gemtuzumab ozogamicin monotherapy.

Walter RB, Gooley TA, van der Velden VH, Loken MR, van Dongen JJ, Flowers DA, Bernstein ID, Appelbaum FR. Walter RB, et al. Among authors: flowers da. Blood. 2007 May 15;109(10):4168-70. doi: 10.1182/blood-2006-09-047399. Epub 2007 Jan 16. Blood. 2007. PMID: 17227830 Free PMC article.

9

The Notch ligand, Jagged-1, influences the development of primitive hematopoietic precursor cells.

Varnum-Finney B, Purton LE, Yu M, Brashem-Stein C, Flowers D, Staats S, Moore KA, Le Roux I, Mann R, Gray G, Artavanis-Tsakonas S, Bernstein ID. Varnum-Finney B, et al. Blood. 1998 Jun 1;91(11):4084-91. Blood. 1998. PMID: 9596653 Free article.

10

Monocytes express high amounts of Notch and undergo cytokine specific apoptosis following interaction with the Notch ligand, Delta-1.

Ohishi K, Varnum-Finney B, Flowers D, Anasetti C, Myerson D, Bernstein ID. Ohishi K, et al. Blood. 2000 May 1;95(9):2847-54. Blood. 2000. PMID: 10779430 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

32 results

Search Page